|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/197 | |
| A61K 33/26 | |||
| A61K 38/19 | |||
| A61K 31/194 | |||
| A61P 37/08 | |||
| A61P 37/06 | |||
| A61P 17/00 |
| (11) | Patento numeris | 2873417 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13816500.6 |
| Europos patento paraiškos padavimo data | 2013-07-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-05-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2013/004130 |
| Data | 2013-07-03 |
| (87) | Numeris | WO 2014/010206 |
| Data | 2014-01-16 |
| (30) | Numeris | Data | Šalis |
| 2012157374 | 2012-07-13 | JP |
| (72) |
TANAKA, Tohru, JP
NAKAJIMA, Motowo, JP
ABE, Fuminori, JP
HAGA, Naomi, JP
TAKAHASHI, Kiwamu, JP
ITO, Hidenori, JP
RII, Ko, JP
|
| (73) |
SBI Pharmaceuticals Co., Ltd.,
6-1, Roppongi 1-chome Minato-ku, Tokyo 106-6020,
JP
National Center For Child Health And Development, 10-1 Okura 2-chome Setagaya-ku, Tokyo 157-8535, JP |
| (54) | IMMUNE TOLERANCE INDUCER |
| IMMUNE TOLERANCE INDUCER |